Zonisamide for Weight Reduction in Obese Adults

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Obesity
Interventions
DRUG

Zonisamide

zonisamide 400 mg, 200 mg, or placebo

Trial Locations (1)

27710

Duke University Medical Centre, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Duke University

OTHER